Cargando…
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study
Organ transplant recipients (OTRs) have a 100‐fold increased risk of cutaneous squamous cell carcinoma (cSCC). We prospectively evaluated the association between β genus human papillomaviruses (βPV) and keratinocyte carcinoma in OTRs. Two OTR cohorts without cSCC were assembled: cohort 1 was transpl...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947129/ https://www.ncbi.nlm.nih.gov/pubmed/29024374 http://dx.doi.org/10.1111/ajt.14537 |
_version_ | 1783322309691441152 |
---|---|
author | Bouwes Bavinck, Jan N. Feltkamp, Mariet C. W. Green, Adele C. Fiocco, Marta Euvrard, Sylvie Harwood, Catherine A. Nasir, Shaaira Thomson, Jason Proby, Charlotte M. Naldi, Luigi Diphoorn, Janouk C. D. Venturuzzo, Anna Tessari, Gianpaolo Nindl, Ingo Sampogna, Francesca Abeni, Damiano Neale, Rachel E. Goeman, Jelle J. Quint, Koen D. Halk, Anne B. Sneek, Carmen Genders, Roel E. de Koning, Maurits N. C. Quint, Wim G. V. Wieland, Ulrike Weissenborn, Sönke Waterboer, Tim Pawlita, Michael Pfister, Herbert |
author_facet | Bouwes Bavinck, Jan N. Feltkamp, Mariet C. W. Green, Adele C. Fiocco, Marta Euvrard, Sylvie Harwood, Catherine A. Nasir, Shaaira Thomson, Jason Proby, Charlotte M. Naldi, Luigi Diphoorn, Janouk C. D. Venturuzzo, Anna Tessari, Gianpaolo Nindl, Ingo Sampogna, Francesca Abeni, Damiano Neale, Rachel E. Goeman, Jelle J. Quint, Koen D. Halk, Anne B. Sneek, Carmen Genders, Roel E. de Koning, Maurits N. C. Quint, Wim G. V. Wieland, Ulrike Weissenborn, Sönke Waterboer, Tim Pawlita, Michael Pfister, Herbert |
author_sort | Bouwes Bavinck, Jan N. |
collection | PubMed |
description | Organ transplant recipients (OTRs) have a 100‐fold increased risk of cutaneous squamous cell carcinoma (cSCC). We prospectively evaluated the association between β genus human papillomaviruses (βPV) and keratinocyte carcinoma in OTRs. Two OTR cohorts without cSCC were assembled: cohort 1 was transplanted in 2003‐2006 (n = 274) and cohort 2 was transplanted in 1986‐2002 (n = 352). Participants were followed until death or cessation of follow‐up in 2016. βPV infection was assessed in eyebrow hair by using polymerase chain reaction–based methods. βPV IgG seroresponses were determined with multiplex serology. A competing risk model with delayed entry was used to estimate cumulative incidence of histologically proven cSCC and the effect of βPV by using a multivariable Cox regression model. Results are reported as adjusted hazard ratios (HRs). OTRs with 5 or more different βPV types in eyebrow hair had 1.7 times the risk of cSCC vs OTRs with 0 to 4 different types (HR 1.7, 95% confidence interval 1.1‐2.6). A similar risk was seen with high βPV loads (HR 1.8, 95% confidence interval 1.2‐2.8). No significant associations were seen between serum antibodies and cSCC or between βPV and basal cell carcinoma. The diversity and load of βPV types in eyebrow hair are associated with cSCC risk in OTRs, providing evidence that βPV is associated with cSCC carcinogenesis and may present a target for future preventive strategies. |
format | Online Article Text |
id | pubmed-5947129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59471292018-05-17 Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study Bouwes Bavinck, Jan N. Feltkamp, Mariet C. W. Green, Adele C. Fiocco, Marta Euvrard, Sylvie Harwood, Catherine A. Nasir, Shaaira Thomson, Jason Proby, Charlotte M. Naldi, Luigi Diphoorn, Janouk C. D. Venturuzzo, Anna Tessari, Gianpaolo Nindl, Ingo Sampogna, Francesca Abeni, Damiano Neale, Rachel E. Goeman, Jelle J. Quint, Koen D. Halk, Anne B. Sneek, Carmen Genders, Roel E. de Koning, Maurits N. C. Quint, Wim G. V. Wieland, Ulrike Weissenborn, Sönke Waterboer, Tim Pawlita, Michael Pfister, Herbert Am J Transplant ORIGINAL ARTICLES Organ transplant recipients (OTRs) have a 100‐fold increased risk of cutaneous squamous cell carcinoma (cSCC). We prospectively evaluated the association between β genus human papillomaviruses (βPV) and keratinocyte carcinoma in OTRs. Two OTR cohorts without cSCC were assembled: cohort 1 was transplanted in 2003‐2006 (n = 274) and cohort 2 was transplanted in 1986‐2002 (n = 352). Participants were followed until death or cessation of follow‐up in 2016. βPV infection was assessed in eyebrow hair by using polymerase chain reaction–based methods. βPV IgG seroresponses were determined with multiplex serology. A competing risk model with delayed entry was used to estimate cumulative incidence of histologically proven cSCC and the effect of βPV by using a multivariable Cox regression model. Results are reported as adjusted hazard ratios (HRs). OTRs with 5 or more different βPV types in eyebrow hair had 1.7 times the risk of cSCC vs OTRs with 0 to 4 different types (HR 1.7, 95% confidence interval 1.1‐2.6). A similar risk was seen with high βPV loads (HR 1.8, 95% confidence interval 1.2‐2.8). No significant associations were seen between serum antibodies and cSCC or between βPV and basal cell carcinoma. The diversity and load of βPV types in eyebrow hair are associated with cSCC risk in OTRs, providing evidence that βPV is associated with cSCC carcinogenesis and may present a target for future preventive strategies. John Wiley and Sons Inc. 2017-11-22 2018-05 /pmc/articles/PMC5947129/ /pubmed/29024374 http://dx.doi.org/10.1111/ajt.14537 Text en © 2017 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | ORIGINAL ARTICLES Bouwes Bavinck, Jan N. Feltkamp, Mariet C. W. Green, Adele C. Fiocco, Marta Euvrard, Sylvie Harwood, Catherine A. Nasir, Shaaira Thomson, Jason Proby, Charlotte M. Naldi, Luigi Diphoorn, Janouk C. D. Venturuzzo, Anna Tessari, Gianpaolo Nindl, Ingo Sampogna, Francesca Abeni, Damiano Neale, Rachel E. Goeman, Jelle J. Quint, Koen D. Halk, Anne B. Sneek, Carmen Genders, Roel E. de Koning, Maurits N. C. Quint, Wim G. V. Wieland, Ulrike Weissenborn, Sönke Waterboer, Tim Pawlita, Michael Pfister, Herbert Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title | Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title_full | Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title_fullStr | Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title_full_unstemmed | Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title_short | Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study |
title_sort | human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: a multicenter, prospective cohort study |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947129/ https://www.ncbi.nlm.nih.gov/pubmed/29024374 http://dx.doi.org/10.1111/ajt.14537 |
work_keys_str_mv | AT bouwesbavinckjann humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT feltkampmarietcw humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT greenadelec humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT fioccomarta humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT euvrardsylvie humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT harwoodcatherinea humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT nasirshaaira humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT thomsonjason humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT probycharlottem humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT naldiluigi humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT diphoornjanoukcd humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT venturuzzoanna humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT tessarigianpaolo humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT nindlingo humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT sampognafrancesca humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT abenidamiano humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT nealerachele humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT goemanjellej humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT quintkoend humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT halkanneb humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT sneekcarmen humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT gendersroele humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT dekoningmauritsnc humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT quintwimgv humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT wielandulrike humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT weissenbornsonke humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT waterboertim humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT pawlitamichael humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT pfisterherbert humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy AT humanpapillomavirusandposttransplantationcutaneoussquamouscellcarcinomaamulticenterprospectivecohortstudy |